NKTR
NASDAQ HEALTHCARENektar Therapeutics
$70.65
Live quote
Loading chart…
P/E Ratio—
P/B Ratio2.67
EV/EBITDA—
Debt/Equity—
ROE-18.17%
ROIC—
Revenue Growth-43.89%
Gross Margin—
Nektar Therapeutics is a biopharmaceutical company. The company is headquartered in San Francisco, California with additional operations in Huntsville, Alabama and Hyderabad, India.
Own NKTR? Track it here.
Create a free account to add NKTR to a portfolio and watch your P/L update in real time.
Custom screens, valuation models and backtesting are coming to Pro.